Behavior of SD-OCT Detectable Hyperreflective Foci in Diabetic Macular Edema Patients after Therapy with Anti-VEGF Agents and Dexamethasone Implants

Table 1

Baseline characteristics of 40 diabetic study patients.

No. of eyes (patients)	59 (51)
Male/female	39/12
Age, years	58,9 (±8)
Diabetic retinopathy stage
Mild NPDR	7
Moderate NPDR	11
Severe NPDR	16
PDR	25
Intravitreal medication
Bevacizumab	19
Ranibizumab	10
Aflibercept	11
Dexamethasone	19
DME type
Focal	8
Diffuse:	51
Central retinal thickness, μm	414.2 (±79.8)
No. hyperreflective foci	131.1 (±103)
No. hard exudates	13.9 (±18)
IS/OS disruption
Yes	7
No	52